Published in South Med J on March 01, 2011
Evaluation of Mean Platelet Volume values in lean women with polycystic ovary syndrome. Pak J Med Sci (2014) 0.78
Thrombocytosis in patients with polycystic ovary syndrome: reactive or culpable? South Med J (2011) 0.75
The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol (2012) 2.44
Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib. J Clin Oncol (2008) 2.38
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib. Oncologist (2008) 2.22
Endometrial regenerative cells: a novel stem cell population. J Transl Med (2007) 2.19
Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis (2005) 1.93
Immunotherapy for melanoma: current status and perspectives. J Immunother (2010) 1.72
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med (2009) 1.62
Novel small interfering RNA-containing solution protecting donor organs in heart transplantation. Circulation (2009) 1.60
Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer. South Med J (2008) 1.58
Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia. Dermatol Online J (2011) 1.49
Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol (2003) 1.41
Malignant melanoma in pigmented skin: does the current interventional model fit a different clinical, histologic, and molecular entity? Dermatol Surg (2013) 1.41
H. pylori-associated gastric cancer in a husband-wife pair: a veritable family affair. South Med J (2009) 1.38
Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia? J Transl Med (2008) 1.27
Behavioral factors of patients before and after diagnosis with melanoma: a cohort study - are sun-protection measures being implemented? Melanoma Res (2010) 1.22
Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol (2010) 1.19
Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J Immunol (2003) 1.11
Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med (2009) 1.10
Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma. Dermatol Online J (2006) 1.09
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med (2010) 1.09
Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant. J Cell Biochem (2006) 1.07
Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res Ther (2006) 1.06
Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia. MedGenMed (2007) 1.04
A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood (2009) 1.04
Selective apoptosis of breast cancer cells by siRNA targeting of BORIS. Biochem Biophys Res Commun (2008) 1.03
Tumor vaccines in 2010: need for integration. Cell Immunol (2010) 1.02
Cord blood in regenerative medicine: do we need immune suppression? J Transl Med (2007) 0.97
Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells. J Immunol (2010) 0.96
Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic. J Transl Med (2013) 0.96
Lasers, stem cells, and COPD. J Transl Med (2010) 0.95
Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin Immunol (2008) 0.95
A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. PLoS One (2012) 0.94
Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sites. J Immunol (2007) 0.93
Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J Immunol (2003) 0.93
Comparison of endometrial regenerative cells and bone marrow stromal cells. J Transl Med (2012) 0.92
Anti-angiogenic effect of high doses of ascorbic acid. J Transl Med (2008) 0.92
Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma? J Clin Oncol (2009) 0.91
LF15-0195 generates tolerogenic dendritic cells by suppression of NF-kappaB signaling through inhibition of IKK activity. J Leukoc Biol (2003) 0.91
Expression of the epigenetic factor BORIS (CTCFL) in the human genome. J Transl Med (2011) 0.90
Small interfering RNA targeting RelB protects against renal ischemia-reperfusion injury. Transplantation (2009) 0.89
A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage. Am J Med Sci (2009) 0.88
RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis. Arthritis Res Ther (2010) 0.88
Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with hereditary ataxia. J Transl Med (2011) 0.88
Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model. Int J Cancer (2012) 0.87
Successful penile replantation with adjuvant hyperbaric oxygen treatment. Urology (2007) 0.87
Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease. Cell Immunol (2010) 0.86
Malignant melanoma in African-Americans. Dermatol Online J (2009) 0.86
Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle (2009) 0.85
Combination stem cell therapy for heart failure. Int Arch Med (2010) 0.85
Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma. South Med J (2007) 0.85
Small cell lung cancer with paraneoplastic lipase production. South Med J (2010) 0.85
A simple and reliable method to blood type monkeys using serum samples. Transpl Int (2009) 0.85
Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med (2009) 0.84
Th1/Th2 xenogenic antibody responses are associated with recipient dendritic cells. Microsurgery (2007) 0.84
A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. J Allergy Clin Immunol (2010) 0.84
Resistance of neonatal porcine Sertoli cells to human xenoantibody and complement-mediated lysis is associated with low expression of alpha-Gal and high production of clusterin and CD59. Xenotransplantation (2010) 0.82
Sea urchin granuloma secondary to Strongylocentrotus purpuratus and Strongylocentrotus franciscanus. Dermatol Online J (2009) 0.82
Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA. J Immunol (2008) 0.82
Acute gout during treatment with paclitaxel for metastatic melanoma. Rheumatology (Oxford) (2009) 0.82
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med (2011) 0.81
Etanercept decreases the innate immune wounding response in psoriasis. Exp Dermatol (2013) 0.80
Resistance to anti-xenogeneic response by combining alpha-Gal silencing with HO-1 upregulation. Transpl Immunol (2008) 0.80
Capecitabine-induced pancolitis. Int J Colorectal Dis (2005) 0.80
Risk of additional cancers in untreated and treated hairy cell leukemia patients. Expert Opin Pharmacother (2010) 0.80
Induction of RNA interference in dendritic cells. Immunol Res (2004) 0.80
On the missing link between inflammation and cancer. Dermatol Online J (2011) 0.80
Cotransplantation with xenogenetic neonatal porcine sertoli cells significantly prolongs islet allograft survival in nonimmunosuppressive rats. Transplantation (2009) 0.80
Chronic lymphocytic leukemia presenting with cholecystitis-like symptoms and gallbladder wall invasion. South Med J (2010) 0.79
Exogenous endothelial cells as accelerators of hematopoietic reconstitution. J Transl Med (2012) 0.79
Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease. Cell Immunol (2008) 0.79
Acute retinal pigment epithelial detachment secondary to pamidronate administration. J Oncol Pharm Pract (2008) 0.78
Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies. Thyroid (2008) 0.78
Inherent and iatrogenic immune defects in hairy cell leukemia: revisited. Expert Opin Drug Saf (2010) 0.78
A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma. Eur J Haematol (2008) 0.78
mTOR-blocking agents in advanced renal cancer: an emerging therapeutic option. Expert Opin Investig Drugs (2009) 0.78
Anti-CD(45)RB monoclonal antibody induces immunologic toleration by suppressing dendritic cells. Transpl Immunol (2009) 0.77
Regulation of allergy with RNA interference. Crit Rev Immunol (2009) 0.77
Carboplatin-gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration. J Oncol Pharm Pract (2009) 0.77
Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells. Transplantation (2003) 0.77
Cardiovascular toxicity associated with small molecule tyrosine kinase inhibitors currently in clinical use. Expert Opin Drug Saf (2012) 0.77
Rapidly fatal acute ATLL emerging after methotrexate therapy for disseminated psoriasis. Clin Lymphoma Myeloma Leuk (2011) 0.76
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. J Transl Med (2014) 0.76
Generalized cerebral atrophy seen on MRI in a naturally exposed animal model for Creutzfeldt-Jakob disease. J Transl Med (2010) 0.76
Modeling hepatitis C virus therapies combining drugs and lectin affinity plasmapheresis. Blood Purif (2010) 0.76
Oligonucleotide based-strategies for allergy with special reference to siRNA. Expert Opin Biol Ther (2009) 0.76
Therapeutic use of Aldara in chronic myeloid leukemia. J Transl Med (2007) 0.76
Enhancement of DNA cancer vaccine efficacy by combination with anti-angiogenesis in regression of established subcutaneous B16 melanoma. Oncol Rep (2009) 0.76
Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe? J Oncol Pharm Pract (2009) 0.75
Bilateral Leser-Trélat sign mirroring lung adenocarcinoma with early metastases to the contralateral lung. South Med J (2009) 0.75
Induction of antitumor immunity through xenoplacental immunization. J Transl Med (2006) 0.75